We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDRH Touts Faster IDE Approval Times, But More Needed to Lure Trials Back Home
CDRH Touts Faster IDE Approval Times, But More Needed to Lure Trials Back Home
The FDA is taking a hard look at ways to bring early-stage device trials back to the U.S., hoping to reverse a decade-long trend that has seen companies moving them overseas.